Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A previously unrecognized drug interaction between quinidine and digoxin.

J A Reiffel, E B Leahey, R E Drusin

    Clinical Cardiology
    |February 1, 1979
    PubMed
    Summary

    Adding quinidine to digoxin therapy significantly increases serum digoxin levels, potentially causing toxicity. Close monitoring of digoxin levels and patient symptoms is crucial when initiating quinidine.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records.

    Applied clinical informatics·2014
    Same author

    Ending the genetic discrimination barrier: regaining confidence in preconception, prenatal, and neonatal genetic testing.

    Southern California law review·2006
    Same author

    Analysis of trends in hospital readmissions and postoperative complications in heart transplant recipients: single center study.

    Transplantation proceedings·2002
    Same author

    Is it rational, reasonable or excessive, and consistently applied? One view of the increasing FDA emphasis on safety first for the release and use of antiarrhythmic drugs for supraventricular arrhythmias.

    Journal of cardiovascular pharmacology and therapeutics·2002
    Same author

    Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.

    The American journal of psychiatry·2001
    Same author

    Importance of QT interval determination and renal function assessment during antiarrhythmic drug therapy.

    Journal of cardiovascular pharmacology and therapeutics·2001

    Area of Science:

    • Cardiology
    • Clinical Pharmacology

    Background:

    • Digoxin is a widely used cardiac glycoside for heart failure and arrhythmias.
    • Quinidine is an antiarrhythmic agent that can interact with other medications.

    Purpose of the Study:

    • To evaluate the interaction between digoxin and quinidine.
    • To assess the impact of quinidine on serum digoxin concentrations and clinical outcomes.

    Main Methods:

    • Retrospective chart review of 863 cardiology patients.
    • Analysis of 27 patients receiving both digoxin and quinidine.
    • Measurement of serum digoxin levels before and during quinidine therapy.

    Main Results:

    • Serum digoxin levels increased in 93% of patients (from 1.4 to 3.2 ng/ml).

    Related Experiment Videos

  • Gastrointestinal symptoms (anorexia, nausea, vomiting) occurred in 59% of patients.
  • New or worsening arrhythmias, including ventricular tachycardia and sudden death, were observed.

    • Conclusions:

    • Quinidine significantly elevates serum digoxin levels.
    • This interaction can lead to digoxin toxicity and adverse cardiac events.
    • Close monitoring of digoxin levels and clinical status is essential when initiating quinidine therapy.